60 minutes
Patients and scientists can experience the arduous trek from drug discovery to treatment from opposite ends. Scientists seek to understand the molecular and cellular basis of a disease to treat or cure a patient population. Meanwhile, patients know the reality of their symptoms and day-to-day limitations. How can we bridge the divide and give scientists the opportunity to step back and hear directly from patients about how their biology affects a person first-hand?

Speakers

Glenda Thomas - Owner at nCeptive, Member of Massachusetts Rare Disease Advisory Council
Michelle Hoarty - Senior Manager, Clinical Science & Biomarker Development, Ra Pharma
Rehan Verjee - Co-founder & CEO, Stealth Start Up
Tracy Antonelli - Beta Thalassemia Patient and Parent